PAULETTE PARKIN-SPENCER: Open Payments
NPI 1811650112 · PALM BAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 11 payments from 9 companies in 2025. Trend: 2023 $277 · 2024 $0 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Analog Devices Inc. | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Kerendia, VERQUVO, LEQVIO, Sensinel CPM Wearable, VYNDAQEL, ONPATTRO, REPATHA, Wegovy.
Industry payments across FL — which companies pay providers there.
